COGNIGENICS
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offset cognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).
COGNIGENICS
Industry:
Genetics Neuroscience Psychology
Founded:
2019-06-26
Website Url:
http://www.cognigenics.io
Total Employee:
1+
Status:
Active
Contact:
772-324-8800
Total Funding:
1.59 M USD
Technology used in webpage:
SPF Apache Euro Sectigo SSL Sectigo Domain SSL Bizland
Similar Organizations
Gratanium
Advertising Agency
Official Site Inspections
http://www.cognigenics.io
- Host name: 138.179.233.35.bc.googleusercontent.com
- IP address: 35.233.179.138
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Cognigenics"
Cognigenics - Investors
EXCEPTIONAL STANDARDS. Our Pioneering Platform: At Cognigenics, our platform formed by modern innovation is redefining its category in the biopharmaceutical realm.Here’s a closer look at its distinguishing features: …See details»
Cognigenics - Crunchbase Company Profile & Funding
Cognigenics conducts preclinical studies to evaluate the safety and efficacy of their RNA-based therapeutics and delivery systems in models before …See details»
Cognigenics - Science
Cognigenics’ breakthrough innovation We have developed a noninvasive delivery platform that overcomes the principal obstacle of transporting genetic edits across the blood-brain barrier. Our approach differs from most contemporary gene …See details»
Cognigenics - Team
Meet the Cognigenics team. Thank you for subscribing! ×See details»
Cognigenics 2025 Company Profile: Valuation, Funding …
Cognigenics General Information Description. Developer of mental healthcare drugs and therapies intended to transform mental health in the genetic age. …See details»
Cognigenics, Inc. - VentureRadar
Cognigenics has developed novel methods for treating a wide range of mental health challenges, from generalized anxiety and chronic depression to cognitive impairment. Our patent-pending …See details»
Cognigenics - Overview, News & Similar companies - ZoomInfo
Jan 16, 2024 www.cognigenics.io. Revenue <$5 Million. Industry Information & Document Management Business Services . Recent News & Media. Intranasal Delivery of shRNA Edits to Silence 5-HT2A Recepto... Mar 21, 2024. www.businesswire.com . David Pyrce Appointed as New CEO of Cognigenics, Inc. Jan 16, 2024. www.businesswire.com . Read more news.See details»
Cognigenics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 16, 2022: Seed Round - …See details»
Cognigenics - Crunchbase
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Cognigenics - Pipeline
At Cognigenics, we are pioneering novel RNA therapeutics to address some of the most prevalent and challenging brain health disorders. Our broad pipeline targets a range of neuropsychiatric …See details»
Cognigenics, Inc. Company Profile | Eagle, ID - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cognigenics, Inc. of Eagle, ID. Get the latest business insights from Dun & Bradstreet. Cognigenics, Inc. …See details»
Chief Administrative Officer (cao) at Cognigenics - The Org
Peter Seidler is a seasoned professional in the fields of innovation, strategic communication, and creative leadership, currently serving as Chief Communications Officer at Cognigenics, a …See details»
Breathe Easy: Non-Invasive Gene Therapy for Anxiety and Memory …
Jan 16, 2025 Director of Preclinical Studies, Troy.rohn@cognigenics.io. Dean Radin is cofounder and chairman of Cognigenics, Chief Scientist at the Institute of Noetic Sciences, …See details»
Cognigenics | CipherBio
Explore Cognigenics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Cognigenics - Overview, News & Similar companies - ZoomInfo
BOISE, Idaho--(BUSINESS WIRE)--Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the …See details»
Cognigenics - 2025 Company Profile, Funding & Competitors
Feb 27, 2025 Cognigenics - Developer of gene therapies for mental health. Raised a total funding of $1.59M over 1 round. Founded by Barry J Linder and Dean Radin in the year 2019. …See details»
Cognigenics - Ethical Commitment
At Cognigenics, we are deeply committed to ethical considerations in our use of genetic treatments for human health. Our approach encompasses several key aspects: Ethical …See details»
Company: Cognigenics - CRISPR Medicine
Cognigenics is a pre-clinical-stage biotech that has developed a method for intranasal adeno-associated virus (AAV)-based delivery of CRISPR-Cas reagents. Cognigenics’ delivery …See details»
Cognigenics' Intranasal CRISPR Delivery Bypasses Blood-Brain …
Jun 22, 2023 Study: method reduced anxiety with no apparent toxicity or neurologic damage. BOISE, Idaho--(BUSINESS WIRE)--Cognigenics CEO John L. Mee announces breakthrough …See details»